About me
Imein Bousnina, Pharm.D, is a Director of U.S. Regulatory Policy at Genentech, a member of the Roche Group. Over her decade at Roche-Genentech, she has served as a subject matter expert and led the implementation of regulatory policy strategies on topics such as FDA and EMA's regulation of alternatives to animal testing, digital health, rare disease drug development, companion diagnostics, and PDUFA, among others. She actively engages in several external groups, including BIO, PhRMA, IQ, EveryLife Foundation for Rare Diseases, and NORD, among others, and has served in leadership roles on some of their taskforces. Imein trained as a pharmacist and holds an MSc in International Regulatory Affairs.
